The efficacy of recombinant feline interferon-omega in treating symptomatic cats infected with feline immunodeficiency virus
PICO Question In symptomatic cats with feline immunodeficiency virus (FIV), does high-dose subcutaneous recombinant feline interferon-omega (rFeIFN-ω) administration lead to reduced clinical signs compared to cats who were not administered rFeIFN-ω? Clinical bottom line Category of research Treatm...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
RCVS Knowledge
2023-09-01
|
| Series: | Veterinary Evidence |
| Subjects: | |
| Online Access: | https://veterinaryevidence.org/index.php/ve/article/view/666 |